Translational Pulmonary Immunology Research Center Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Translational Pulmonary Immunology Research Center's estimated annual revenue is currently $27.5M per year.(i)
  • Translational Pulmonary Immunology Research Center's estimated revenue per employee is $270,000

Employee Data

  • Translational Pulmonary Immunology Research Center has 102 Employees.(i)
  • Translational Pulmonary Immunology Research Center grew their employee count by 5% last year.

Translational Pulmonary Immunology Research Center's People

NameTitleEmail/Phone
1
Founder, CEO, Chief Medical & Scientific OfficerReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Director ResearchReveal Email/Phone
4
Major Gifts OfficerReveal Email/Phone
5
Director Billing OperationsReveal Email/Phone
6
Research Laboratory ManagerReveal Email/Phone
7
Clinical Office ManagerReveal Email/Phone
8
Physician Assistant StudentReveal Email/Phone
9
Food TechnologistReveal Email/Phone
10
Physician AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$363.6M703-6%N/AN/A
#2
$4.9M26-4%N/AN/A
#3
$16.3M67-4%N/AN/A
#4
$45.7M14118%N/AN/A
#5
$22.4M663%N/AN/A
#6
$108.3M2656%N/AN/A
#7
$128.9M3063%N/AN/A
#8
$20.5M53-10%N/AN/A
#9
$762.2M19784%$1.1BN/A
#10
$1690M113326%N/AN/A
Add Company

What Is Translational Pulmonary Immunology Research Center?

TPIRC is a non-profit clinical care and research center that focuses on the development of cutting-edge, individualized treatment protocols for rare and orphan diseases utilizing comprehensive diagnostic tools and patient-driven research. Our mission is two-fold- to advance treatment discovery at a pace which helps our patients today, while building a scalable model of success to accelerate the rate of research discovery for all diseases.

keywords:research, non-profit, clinic, startup, healthtech, allergies, pulmonary

N/A

Total Funding

102

Number of Employees

$27.5M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Translational Pulmonary Immunology Research Center News

2022-04-17 - Inhibrx Announces Formation of Scientific Advisory Board for INBRX-101

Dr. Barjaktarevic received his Ph.D. in pulmonary immunology in 2016. ... in rare lung disease translational research with a focus on AATD,...

2022-04-17 - New study bolsters support for novel "off-the-shelf" CAR-T cells

The findings, published Friday in Science Immunology, are the latest to come ... A Sloan Kettering Institute research team thinks new, killer, innate-like T...

2022-04-06 - Hope for stroke? Protein could limit damage by shielding parts ...

The findings, published Friday in Science Immunology, are the latest to ... A Sloan Kettering Institute research team thinks new, killer,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M10219%N/A
#2
$26.1M10313%N/A
#3
$30.6M103-4%N/A
#4
$18.2M10424%N/A
#5
$23.1M10525%N/A